CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- 4 Option exercise Director acquired 2,120 shares (option exercise)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change · Shareholder vote results
- 4 Option exercise Director acquired 1,977 shares (option exercise)
- 4 Option exercise Director acquired 1,977 shares (option exercise)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 4 Planned sale Director sold 7,497 shares at $25.90 ($194,172)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
Page 8 of 66 · 1,304 filings